Clinical Trial Update: Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating high-dose vitamin D on cancer biomarkers and breast cancer tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Invasive Breast Cancer

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Eli Avisar, MD | Conditions: Breast Cancer, Invasive Breast Carcinoma | Phase 1, Phase 2 | Status: WITHDRAWN